Here's Wouldn't Touch Moderna: Why I Won't Bet on Its Next Growth Engine
Moderna surged on pandemic-era demand. But what comes next? This piece examines why some investors are wary, what a t...
Knowing the average retirement savings for 30-year-olds helps gauge your financial health. Learn the benchmarks to aim for as you save.
23,529 articlesModerna surged on pandemic-era demand. But what comes next? This piece examines why some investors are wary, what a t...
Fresh analyst calls on Tuesday cover a diverse set of names from Blackstone to Qualcomm, signaling continued caution ...
Meta Platforms is negotiating a landmark AI hardware pact with AMD that could top $100 billion, including an option f...
As XPEL gears up for 2025 earnings insights, investors need a clear view of growth drivers, margin discipline, and po...
In competitive real estate markets, the highest bid often loses to the quickest, most certain offer. This guide shows...
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Apple unveiled a refreshed iPhone and iPad Air lineup with bigger storage, underscoring a broader AI push. The move a...
As markets swing in early 2026, performing defensive stocks have provided steadier returns, drawing cash into staples...
As volatility remains a theme, smart investors are looking for growth stocks first half opportunities with real catal...
B&G Foods is in the spotlight as its stock roars higher. This article explains the mix of quarterly results, strategi...
The S&P 500 has slipped to a just 3-month low even as oil prices climb. This article breaks down what this divergence...
Two AI-powered forecasts tilt in favor of XRP versus Bitcoin through 2026. ChatGPT and DeepSeek paint a scenario wher...